IBJNews

Indianapolis-based Xylogenics licenses yeast strain to ethanol producer

Back to TopCommentsE-mailPrintBookmark and Share
On The Beat Industry News In Brief

Indianapolis-based bioengineering firm Xylogenics Inc. has licensed its proprietary yeast strain to a Milwaukee firm that is a supplier to the fuel-ethanol industry. It is the first such licensing agreement for Xylogenics.

Lallemand Ethanol Technology will use Xylogenics’ yeast strain, which is notable in its potential to produce ethanol from cheap, abundant plant matter, such as grasses and the leftover portion of a corn stalk. Most ethanol is made from corn kernels, a food crop whose price has risen with the demand for ethanol.

Xylogenics claims its yeast strain, developed at the Indiana University School of Medicine, can increase yields and lower costs of producing corn ethanol.

Terms of the deal were not disclosed.

“We are confident that our combined strengths will allow us to move quickly to commercialization and make a positive impact on the fuel-ethanol industry economics,” said Mike Neibler, CEO of Xlyogenics.

The ethanol industry is trying to slash production costs to make E85—a mix of 85 percent ethanol and 15 percent gasoline—more competitive with gasoline. The industry is also lobbying federal agencies to permit the blending of a higher percentage of ethanol into ordinary gasoline. Most gasoline is blended with no more than 10 percent ethanol.

The eight-employee Xlyogenics is based at the Indiana University Emerging Technology Center along the Central Canal. It was funded by $150,000 from IU faculty and from the Lugar Center for Renewable Energy. Earlier this year, it lassoed $225,000 from angel investors affiliated with the University of Notre Dame.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT